NOTE: This supplement is only available to read in selected countries and geographies
[geoip-content country=”AT, BE, BG, HR, CY, CZ, DK, EE, FI, FR, DE, GR, HU, IE, IT, LV, LT, LU, MT, NL, PL, PT, RO, SK, SI, CH, ES, SE, GB, AL, AD, AM, AZ, BY, BA, GE, IS, KZ, LI, MD, MC, ME, MK, NO, RU, SM, RS, CH, TR, UA, VA”]
In this supplement, sponsored by Medtronic:
- From a bailout procedure to a standardised therapeutic option: Ten-year anniversary of the first publication of abdominal use of ChEVAR in symptomatic patients, Giovanni Torsello
- Patient selection: Insights from the PROTAGORAS 2.0 study regarding adequate preoperative sizing and planning, Stefano Fazzini
- The procedure step by step: Which are the critical moments and what should be avoided? Konstantinos Donas
- How ChEVAR changed our approach in hostile AAA necks, Cornelis JJM Sikkink & Lee H Bouwman
- How ChEVAR changed my practice with inadequate infrarenal sealing zones, Antonio Giménez Gaibar
- Case report: Complex symptomatic aortoiliac aneurysm: ChEVAR is the solution, Sébastien Déglise & Celine Deslarzes-Debuis
- Latest clinical evidence on ChEVAR: What is next? Gergana T Taneva
[/geoip-content]
